Akın Yılmaz

1.0k total citations
50 papers, 842 citations indexed

About

Akın Yılmaz is a scholar working on Molecular Biology, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Akın Yılmaz has authored 50 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 9 papers in Pharmacology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Akın Yılmaz's work include Hearing, Cochlea, Tinnitus, Genetics (5 papers), Inflammatory mediators and NSAID effects (5 papers) and Synthesis and biological activity (4 papers). Akın Yılmaz is often cited by papers focused on Hearing, Cochlea, Tinnitus, Genetics (5 papers), Inflammatory mediators and NSAID effects (5 papers) and Synthesis and biological activity (4 papers). Akın Yılmaz collaborates with scholars based in Türkiye, Italy and Germany. Akın Yılmaz's co-authors include Sevda Menevşe, Ece Konaç, Ebru Alp, Adnan Menevşe, Hacer İlke Önen, Sultan Nacak Baytaş, Mehmet Ali Ergün, Ediz Yeşilkaya, Yıldırım A. Bayazit and Peyamı Cınaz and has published in prestigious journals such as The American Journal of Cardiology, Molecules and Urology.

In The Last Decade

Akın Yılmaz

49 papers receiving 826 citations

Peers

Akın Yılmaz
Akın Yılmaz
Citations per year, relative to Akın Yılmaz Akın Yılmaz (= 1×) peers Alireza Shirazi

Countries citing papers authored by Akın Yılmaz

Since Specialization
Citations

This map shows the geographic impact of Akın Yılmaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akın Yılmaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akın Yılmaz more than expected).

Fields of papers citing papers by Akın Yılmaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akın Yılmaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akın Yılmaz. The network helps show where Akın Yılmaz may publish in the future.

Co-authorship network of co-authors of Akın Yılmaz

This figure shows the co-authorship network connecting the top 25 collaborators of Akın Yılmaz. A scholar is included among the top collaborators of Akın Yılmaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akın Yılmaz. Akın Yılmaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alp, Ebru, et al.. (2017). Effects of EF-24, RAD001, and paclitaxel on the expression profiles of apoptotic and anti-apoptotic genes. Journal of Cancer Research and Therapeutics. 13(2). 346–346.
2.
Çakır, Ömer Onur, et al.. (2016). Association of the BsmI, ApaI, TaqI, Tru9I and FokI Polymorphisms of the Vitamin D Receptor Gene with Nephrolithiasis in the Turkish Population.. PubMed. 13(1). 2509–18. 22 indexed citations
3.
Varol, Nuray, Ece Konaç, Serhat Gürocak, et al.. (2014). The Epigenetically Regulated Effects of Wnt Antagonists on the Expression of Genes in the Apoptosis Pathway in Human Bladder Cancer Cell Line (T24). DNA and Cell Biology. 33(7). 408–417. 11 indexed citations
4.
Gürbüz, Venhar, Ece Konaç, Nuray Varol, et al.. (2014). Effects of AG490 and S3I-201 on regulation of the JAK/STAT3 signaling pathway in relation to angiogenesis in TRAIL-resistant prostate cancer cells in vitro. Oncology Letters. 7(3). 755–763. 34 indexed citations
5.
Baytaş, Sultan Nacak, Akın Yılmaz, Abdurrahman Olğaç, et al.. (2014). Synthesis, biological evaluation and molecular docking studies of trans-indole-3-acrylamide derivatives, a new class of tubulin polymerization inhibitors. Bioorganic & Medicinal Chemistry. 22(12). 3096–3104. 52 indexed citations
6.
Yılmaz, Akın. (2014). Bioinformatic Analysis of GJB2 Gene Missense Mutations. Cell Biochemistry and Biophysics. 71(3). 1623–1642. 16 indexed citations
7.
Sayin, Aslıhan, et al.. (2013). Effects of the Adverse Life Events and Disrupted in Schizophrenia-1 ( DISC1 ) Gene Polymorphisms on Acute Symptoms of Schizophrenia. DNA and Cell Biology. 32(2). 73–80. 4 indexed citations
8.
Yaman, Emel, et al.. (2013). Effects of cisplatin and panobinostat on human mesothelial (Met-5A) and malignant pleural mesothelioma (MSTO-211H) cells. Genetics and Molecular Research. 12(4). 5405–5413. 4 indexed citations
9.
Çelenk, Fatih, et al.. (2013). Expression of Cyclooxygenase-2, 12-Lipoxygenase, and Inducible Nitric Oxide Synthase in Head and Neck Squamous Cell Carcinoma. Journal of Craniofacial Surgery. 24(4). 1114–1117. 15 indexed citations
10.
Ergin, Volkan, Akın Yılmaz, Fatih Çelenk, et al.. (2012). COX-2, ALOX12 ve iNOS genlerinin nazal polipozisteki rolü. The Turkish Journal of Ear Nose and Throat. 22(5). 254–258. 1 indexed citations
11.
Konaç, Ece, et al.. (2011). Evaluation of the Effects of the Flavonoid Apigenin on Apoptotic Pathway Gene Expression on the Colon Cancer Cell Line (HT29). Journal of Medicinal Food. 14(10). 1107–1117. 60 indexed citations
12.
Karamert, Recep, et al.. (2011). Association of GJB2 gene mutation with cochlear implant performance in genetic non-syndromic hearing loss. International Journal of Pediatric Otorhinolaryngology. 75(12). 1572–1575. 21 indexed citations
13.
Gürocak, Serhat, Akın Yılmaz, Ebru Alp, et al.. (2011). Inflammation and Oxidative Stress in Testicular Torsion: Do They Deserve Intensive Treatment to Save Both Guilty and Innocent Testes?. Urology. 78(1). 164–169. 7 indexed citations
14.
Alp, Ebru, Sevda Menevşe, Murat Tulmaç, et al.. (2010). The Role of Matrix Metalloproteinase-2 Promoter Polymorphisms in Coronary Artery Disease and Myocardial Infarction. Genetic Testing and Molecular Biomarkers. 15(4). 193–202. 27 indexed citations
15.
Yılmaz, Akın, Sevda Menevşe, Metin Onaran, et al.. (2010). E-cadherin gene 3′-UTR C/T polymorphism in Turkish patients with nephrolithiasis. Molecular Biology Reports. 38(8). 4931–4934. 1 indexed citations
16.
Onaran, Metin, Akın Yılmaz, Mehmet Ali Ergün, et al.. (2009). A HindIII Polymorphism of Fibronectin Gene Is Associated With Nephrolithiasis. Urology. 74(5). 1004–1007. 11 indexed citations
17.
Ergün, Mehmet Ali, et al.. (2008). Serotonin Transporter Gene Polymorphisms and Sertraline Response in Major Depression Patients. Genetic Testing. 12(2). 225–231. 38 indexed citations
18.
Baysal, Elif, Yıldırım A. Bayazit, Serdar Ceylaner, et al.. (2008). GJB2 and mitochondrial A1555G gene mutations in nonsyndromic profound hearing loss and carrier frequencies in healthy individuals. Journal of Genetics. 87(1). 53–57. 17 indexed citations
19.
Yılmaz, Akın, Sevda Menevşe, Aycan Fahri Erkan, et al.. (2007). The Relationship of the ESR1 Gene Polymorphisms with the Presence of Coronary Artery Disease Determined by Coronary Angiography. Genetic Testing. 11(4). 367–372. 15 indexed citations
20.
Konaç, Ece, et al.. (2005). Effects of diethylstilbestrol in human lymphocytes in vitro: A dose and time-dependent study on genotoxic, cytotoxic and apoptotic effects. Molecular and Cellular Biochemistry. 276(1-2). 45–53. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026